Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride can cause rare breast growth side effect, with varying recovery after stopping.

The book "Diseases of the Hair and Scalp" has outdated information and confusing content, but may still offer some insights.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Escitalopram might effectively treat delusions of parasitosis and possibly Morgellons disease, with psychological factors being important to consider.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Genetic mutations cause various hair diseases, and whole genome sequencing may reveal more about these conditions.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

The 190-kbp domain contains all human type I hair keratin genes, showing their organization and evolution.

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

People with Down syndrome often have skin issues and need regular check-ups for early treatment.

Some immunosuppressed patients can get unusual skin infections from Malassezia, which can be treated with antifungal medication.

The document discusses various challenging skin conditions and their treatments.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Dermatoscopy is a useful tool for diagnosing hair disorders and can help choose samples for more detailed analysis.